Slovakia's Health Ministry Awaits Court Ruling on Most Expensive Drug's Reimbursement Status

Slovakia's Health Ministry remains without a court ruling regarding the cancellation of reimbursement status for the country's most expensive medication. The drug, which costs approximately two million euros, had its public funding categorization challenged in court proceedings that are still pending. The medication's high cost made it a significant burden on Slovakia's public healthcare budget when it was originally approved for state reimbursement. The court's decision will determine whether patients will continue to receive public funding for this costly treatment or whether they will need to seek alternative financing options.